ecancermedicalscience

Conference Report

Eurocan Platform meeting: European recommendations for biomarker-based chemoprevention trials

8 Dec 2014
Linda Cairns

Chemoprevention or the now more preferred ‘cancer prevention’ is the long-term administration of a biological or chemical agent to reduce the risk of cancer. This approach has long been active in individuals at high risk of developing breast or colon cancer. The aim of this expert meeting was to review the current status of the field of cancer prevention and potential, emerging biomarkers specifically focusing on breast, colon, and lung cancer but also with sessions on ovary and prostate.

Related Articles

Sasongko Hadi Priyono, Winardi Budiwinata, Budianto Tedjowitono, Effendy, Muhamad Daffa Ibnurasy Pratama
Rohini Sebastian, Josh Thomas Georgy, Arun George, Prisca Santhanam, Raiza Philip, Anjana Joel, Ajoy Oommen John, Deepa Susan Joy Philip, Divya Bala Thumaty, Thomas Alex Kodiatte, Ashish Singh, Rekha Pai
Ghazal Tansir, Akhil Santhosh, Akash Kumar, Hemavathi Baskarane, Mohit Kumar Divakar, Vishakha Hooda, Arundhati J R Dev, Chandra Prakash Prasad, Ishaan Gupta, Saran Kumar, Pranay Tanwar, Atul Sharma, Sameer Bakhshi, Atul Batra
María Florencia Illia, Giuliana Colucci, Angeles Ballester, Mariana Eiben, Fernando Paesani, Francisco Von Stecher, Máximo de la Vega, Florencia Perazzo, Pablo Mandó
Sidhart Misra, Zainab Yusufali Motiwala, Ayyaz Mulla, Jagatheswaran Chinnathambi, Danny Darlington Carbin
Faiza Ahmed, Aqsa Amjad, Eman Anwar, Mohammad Saad Saleem Naviwala, Warda Saleem, Nawazish Zehra, Munira Moosajee, Yasmin Abdul Rashid